Washington, DC, United States of America

David William Lafleur

This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Immune Therapies. Top assignees: Arcellx, Inc., Subdomain, LLC, Human Genome Sciences, Inc.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David William Lafleur. Retrieved from https://idiyas.com/inventor/david-william-lafleur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 7)

% Patents Active = 94.1

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 149(Granted Patents)

Location History:

Washington, DC (US) (2002 - 2023)
Gaithersburg, MD (US) (2023)

Company Filing History:

Human Genome Sciences, Inc.

Teva Pharmaceutical Industries Limited

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Binding Polypeptides

Immune Cell Therapies

Modular Recognition Domains

Multispecific Complexes

Angiopoietin-2

EGFR-Binding

Pharmaceutical Compositions

Human Secreted Proteins

D-Domain Polypeptides

Polynucleotides

BChE Albumin Fusions

Therapeutic Applications

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12780932 - MULTIFUNCTIONAL IMMUNE CELL THERAPIES (2026-11-03),

2. 12528872 - DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF (2026-01-20),

3. 12358995 - De novo binding domain containing polypeptides and uses thereof (2025-07-15),

4. 12338294 - D-domain containing polypeptides and uses thereof (2025-06-24),

5. 11827716 - D-domain containing polypeptides and uses thereof (2023-11-28),

6. 11730763 - Multifunctional immune cell therapies (2023-08-22),

7. 11008397 - De novo binding domain containing polypeptides and uses thereof (2021-05-18),

8. 10662248 - De novo binding domain containing polypeptides and uses thereof (2020-05-26),

9. 10647775 - De novo binding domain containing polypeptides and uses thereof (2020-05-12),

10. 10526381 - Multivalent and monovalent multispecific complexes and their uses (2020-01-07),

11. 10150800 - EGFR-binding modular recognition domains (2018-12-11),

12. 10087222 - Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides (2018-10-02),

13. 9676833 - Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof (2017-06-13),

14. 8541373 - BChE albumin fusions for the treatment of cocaine abuse (2013-09-24),

15. 6525174 - Precerebellin-like protein (2003-02-25),

Title: The Innovative Journey of David William Lafleur

Introduction:

David William Lafleur, a pioneering inventor based in Washington, DC, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents:

David Lafleur's latest patents include a cutting-edge virtual reality headset that revolutionizes the gaming industry, a patented smart home device that enhances security systems, and a unique medical device designed to improve patient care.

Career Highlights:

With a career spanning over two decades, David Lafleur has established himself as a leading figure in the world of innovation. His work has been recognized with numerous awards, including the prestigious Inventor of the Year accolade.

Collaborations:

Throughout his career, David Lafleur has collaborated with top technology companies, research institutions, and universities to bring his inventions to life. His partnerships have led to the development of groundbreaking technologies that have transformed various industries.

Conclusion:

In conclusion, David William Lafleur's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the field of technology continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.